arrow
C

Cristina Gasparetto

Duke University Medical Center
H指数:43
被引数:7,127

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Venetoclax or placebo in combination with bortezomib and dexamethasone in relapsed or refractory multiple myeloma (BELLINI): final overall survival results from a randomised, phase 3 study

维奈克拉或安慰剂联合硼替佐米和地塞米松治疗复发或难治性多发性骨髓瘤(BELLINI):一项随机、III期研究的最终总生存结果

2025-06-270
PRE
Treatment Patterns, Efficacy, and Tolerability of Belantamab Mafodotin in Patients With Relapsed and/or Refractory Multiple Myeloma: A Real-World Analysis

治疗模式、疗效和耐受性:Belantamab Mafodotin 在复发和/或难治性多发性骨髓瘤患者中的真实世界分析

2025-04-150
PRE
Expert Perspectives on Current Challenges and Emerging Approaches for Multiple Myeloma: Narrative Review of an Inaugural Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma

多发性骨髓瘤当前挑战与新兴策略的专家观点:白血病、淋巴瘤和多发性骨髓瘤领域“弥合差距”首届叙事综述

2025-03-110
PRE
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial

Elranatamab治疗复发或难治性多发性骨髓瘤: MagnetisMM-1的1期临床试验

2023-10-0246
OAAI
A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial
2023-06-014
OAAI
A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease

Fostamatinib抑制SYK在预防和治疗慢性移植物抗宿主病中的I期试验

2023-03-0110
OAAI
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

三联疗法,移植和维持直到骨髓瘤进展

2022-07-14241
OA
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma
2022-05-2114
OAAI
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients
2021-11-2025
OA
Female Sex Is Associated with Improved Long-Term Survival Following Allogeneic Hematopoietic Stem Cell Transplantation

女性与异基因造血干细胞移植后长期生存率提高相关

2021-09-019
OAAI
Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies

血液系统恶性肿瘤患者脐带血移植与匹配的相关或匹配的无关供体移植相比,1年幸存者的死亡率降低

2021-08-014
OAAI
A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab
2021-05-1258
OAAI
Assessing the Feasibility of a Novel mHealth App in Hematopoietic Stem Cell Transplant Patients
2021-02-0114
OAAI
Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma
2021-01-1978
OAAI